β-Secretase Inhibitor II l monopotassium) 4-dimethoxybenzeneacetamide

4-dimethoxybenzeneacetamide

Targeted drug delivery through the traceless release of tertiary and heteroaryl amines from antibody-drug conjugates

GW791343 inhibits responses at the human–rat chimeric receptor in both sucrose and NaCl buffer

16S)-15-((S)-2-((S)-5-amino-1-((S)-4-amino-1-carboxy-4-oxobutylamino)-1

GMB-475 (0-30 μM) induces the degradation of BCR-ABL1 and c-ABL1 with concomitant inhibition of downstream signaling via the STAT5 pathway

β-Secretase Inhibitor II l monopotassium) 4-dimethoxybenzeneacetamideSecretase Inhibitor II is a Secretase inhibitor. Secretase Inhibitor II is a simple tripeptide aldehyde (IC50=700 nM for inhibition of total A and IC50=2. 5 M for A142). Secretase Inhibitor II can be used for the research of Alzheimer's disease. Product information CAS Number: 263563 09 3 Molecular Weight: 461. 59 Formula: C25H39N3O5 Chemical Name: benzyl N [(1S) 2 methyl 1 {[(1S) 3 methyl 1 {[(2S) 4 methyl 1 oxopentan 2